stimOS GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
stimOS GmbH - overview
Established
2015
Location
Konstanz, -, Germany
Primary Industry
Medical Devices & Equipment
About
stimOS GmbH is a German innovator specializing in advanced implant materials that enhance biological integration for medical applications. Their focus includes developing biosimilar systems tailored for spinal and dental uses. Founded in 2015 in Konstanz, Germany, stimOS GmbH operates in the development of innovative implant materials. The company has successfully raised EUR 0.
720 mn in Seed funding from investors including High-Tech Gründerfonds and MBG Baden-Württemberg. The founders, Helmut Cölfen and Johannes Boneberg, have not publicly detailed prior ventures. As of August 2020, stimOS has completed two funding deals, with a current company valuation of EUR 4. 706 mn.
Golden Standard Technologies, through stimOS GmbH, focuses on innovative implant materials that facilitate biological integration. Key products include spineFuse for spinal applications and smartDENT for dental uses, utilizing proprietary Mimicking Bone Technology (MBT) to enhance early bone formation and secure anchorage. Their client base mainly consists of implant manufacturers and healthcare providers across Europe, with plans for international expansion. stimOS GmbH's revenue model relies on direct business-to-business transactions, supplying advanced implant technologies to manufacturers in the orthopedic and dental sectors.
Their partnerships emphasize long-term relationships, benefiting from stimOS’s expertise in surface functionalization technologies while adhering to stringent quality and regulatory standards, including ISO 13485:2016 certification. Specific financial agreements are based on delivery schedules and order volumes, but exact pricing remains proprietary. stimOS GmbH aims to launch new products and expand into additional markets. Following their latest funding round in August 2020, which raised EUR 0.
720 mn, the company plans to utilize these resources to enhance product development and optimize their market strategies. They are specifically targeting growth in international markets to diversify their customer base, aligning with their commitment to meet varying patient and surgeon needs.
Current Investors
High-Tech Gruenderfonds, MBG Baden-Wuerttemberg, WEFA Singen GmbH
Primary Industry
Medical Devices & Equipment
Sub Industries
Dental Products & Services, Chiropractic, Orthopedic & Physical Therapy, Surgical Devices
Website
www.smartimplants.net
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
stimOS GmbH - financials
| Fiscal Year Ended | Dec 31, 2017 | Dec 31, 2018 |
|---|---|---|
| Revenue (USD) | - | - |
| % Revenue Growth (YoY) | - | - |
| EBITDA (USD) | - | - |
| Operating Income (USD) | - | - |
| Operating Margin | - | - |
| % EBITDA Margin | - | - |
| NET Income (USD) | - | - |
| % Net Margin | - | - |
stimOS GmbH - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A | Completed | stimOS GmbH | - | ||||||||
| Seed | Completed | stimOS GmbH | - |
Displaying 1 - 2 of 2
stimOS GmbH - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.